These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2686770)

  • 21. Long-term prognosis in patients treated for erythema chronicum migrans and acrodermatitis chronica atrophicans.
    Hulshof MM; Vandenbroucke JP; Nohlmans LM; Spanjaard L; Bavinck JN; Dijkmans BA
    Arch Dermatol; 1997 Jan; 133(1):33-7. PubMed ID: 9006370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serologic studies of erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans with indirect immunofluorescence and enzyme-linked immunosorbent assays.
    Asbrink E; Hovmark A; Hederstedt B
    Acta Derm Venereol; 1985; 65(6):509-14. PubMed ID: 2420115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Serodiagnosis of Lyme borreliosis: antibody titer and specificity in the IFT and western blot].
    Grellner W; Erbguth F; Brade V
    Immun Infekt; 1989 Dec; 17(6):189-94. PubMed ID: 2693341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythema chronicum migrans disease in the Federal Republic of Germany.
    Schmidt R; Kabatzki J; Hartung S; Ackermann R
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Feb; 263(3):435-41. PubMed ID: 3591095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
    Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
    Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lyme borreliosis].
    Weber K
    Hautarzt; 1986 Nov; 37(11):583-6. PubMed ID: 3542901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of serum antibodies against Borrelia burgdorferi with some commercially available serological tests.
    Melby K; Steinbakk M; Jensenius M; Figenschau KJ
    NIPH Ann; 1990 Dec; 13(2):37-44. PubMed ID: 2093855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lyme borreliosis: underdiagnosed?--overtreated?].
    Peuckert W
    Monatsschr Kinderheilkd; 1990 Apr; 138(4):190-5. PubMed ID: 2192269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymerase chain reaction for detection of Borrelia burgdorferi DNA in skin lesions of early and late Lyme borreliosis.
    von Stedingk LV; Olsson I; Hanson HS; Asbrink E; Hovmark A
    Eur J Clin Microbiol Infect Dis; 1995 Jan; 14(1):1-5. PubMed ID: 7729446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acrodermatitis chronica atrophicans in the course of old Lyme disease].
    Zdrodowska A; Zajkowska J; Grygorczuk S; Pancewicz S; Kondrusik M
    Pol Merkur Lekarski; 2001 Sep; 11(63):263-5. PubMed ID: 11761826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lyme borreliosis: how is it manifested in Spain?].
    Guerrero A; Quereda C; Martí-Belda P; Escudero R
    Med Clin (Barc); 1993 May; 101(1):5-7. PubMed ID: 8315978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Borrelia burgdorferi in the nervous system: the new "great imitator".
    Pachner AR
    Ann N Y Acad Sci; 1988; 539():56-64. PubMed ID: 3190104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lyme borreliosis yesterday, today and tomorrow].
    Wahlberg P
    Duodecim; 1995; 111(14):1298-303. PubMed ID: 9244679
    [No Abstract]   [Full Text] [Related]  

  • 34. Atypical Lyme borreliosis in an HIV-infected man.
    Cordoliani F; Vignon-Pennamen MD; Assous MV; Vabres P; Dronne P; Rybojad M; Morel P
    Br J Dermatol; 1997 Sep; 137(3):437-9. PubMed ID: 9349345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease expression of Lyme borreliosis in northeastern France.
    Lipsker D; Hansmann Y; Limbach F; Clerc C; Tranchant C; Grunenberger F; Caro-Sampara F; Attali P; Frey M; Kubina M; Piémont Y; Sibilia J; Jaulhac B;
    Eur J Clin Microbiol Infect Dis; 2001 Apr; 20(4):225-30. PubMed ID: 11399010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology of borrelia infections in Austria.
    Stanek G; Flamm H; Groh V; Hirschl A; Kristoferitsch W; Neumann R; Schmutzhard E; Wewalka G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Feb; 263(3):442-9. PubMed ID: 3591096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Etiology of acrodermatitis chronica atrophicans and erythema chronicum migrans].
    Herrmann WP
    Z Hautkr; 1986 Apr; 61(8):515-21. PubMed ID: 3521114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Skin manifestations of Lyme borreliosis].
    Nammous AH; Zubacki D; Dobrzycki I
    Przegl Lek; 2006; 63(4):227-30. PubMed ID: 17080746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Joint and bone involvement in Dutch patients with Lyme borreliosis presenting with acrodermatitis chronica atrophicans.
    Houtman PM; Tazelaar DJ
    Neth J Med; 1999 Jan; 54(1):5-9. PubMed ID: 10048289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of class II molecules on epidermal Langerhans cells in Lyme borreliosis.
    Silberer M; Koszik F; Stingl G; Aberer E
    Br J Dermatol; 2000 Oct; 143(4):786-94. PubMed ID: 11069457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.